Lmito Therapeutics
PrivateLast Round
Series A
Aug 31, 2020
Total Funding Raised
$5.89M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lmito Therapeutics is a clinical-stage pharmaceutical company that develops novel therapies for autoinflammatory, autoimmune, and fibrotic diseases through metabolic reprogramming.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lmito Therapeutics Comparables
Compare Lmito Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sitryx | 85% | |
| Capacity Bio | 78% | |
| Innovo Therapeutics | 78% |
Lmito Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 31, 2020 |
Key People
Founding team and executive leadership
Lmito Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dt& Investment | Series A |
| Yuanta Investment | Series A |
| Kiwoom Investment | Series A |
| Stonebridge Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 346% MoM, from 290 to 1.3K.
- Jan 22, 2026
Monthly visitors grew 98% MoM, reaching 3.6K.
Lmito Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lmito Therapeutics's valuation, stock price, and market status.
Is Lmito Therapeutics a public or private company?
Lmito Therapeutics is a private company.
What is the current stock price of Lmito Therapeutics?
Lmito Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Lmito Therapeutics worth (valuation)?
Valuation information for Lmito Therapeutics is not publicly available.
Can I buy Lmito Therapeutics stock?
Lmito Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lmito Therapeutics's last funding round?
Lmito Therapeutics's most recent funding round was Series A on August 31, 2020.
Who are the main investors in Lmito Therapeutics?
Key investors in Lmito Therapeutics include Dt& Investment, Yuanta Investment, Kiwoom Investment, Stonebridge Ventures.
Will Lmito Therapeutics IPO soon?
No public IPO plans have been announced for Lmito Therapeutics.
How can I track Lmito Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lmito Therapeutics's secondary market activity and sign up for updates.